Global Genomics Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Genomics market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Genomics market."
Genetics is about genetic research subject, the human genome project was first proposed in 1985, scientists in the us to clarify the sequence of the human genome 3 billion base pairs, discovered that all human genes and figure out its location on chromosome, all to decipher the human genetic information, make comprehensive understanding at the molecular level for the first time.
The increasing awareness of genomics and reducing DNA sequencing costs are expected to drive the growth of the segment.

The global Genomics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Genomics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Genomics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    ILLUMINA
    AGILENT TECHNOLOGIES
    THERMO FISHER SCIENTIFIC
    EUROFINS SCIENTIFIC
    QIAGEN
    GE HEALTHCARE
    F. HOFFMANN-LA ROCHE
    OXFORD NANOPORE TECHNOLOGIES
    BIO-RAD LABORATORIES
    BGI
    EPPENDORF
    PACIFIC BIOSCIENCES OF CALIFORNIA
    DANAHER

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Sequencing
    Microarray
    PCR

Segment by Application
    Diagnosis
    Drug Development
    Precision Medical
    Agricultural
    Other